Objective An increased red cell distribution width (RDW) has been reported to be associated with adverse outcomes in patients with heart failure (HF). This study aimed to evaluate the prognostic power of the combined measurement of RDW and B-type natriuretic peptide (BNP) concentrations in patients with HF.
Introduction
Intern Med 57: 1681-1688, 2018 DOI: 10.2169/internalmedicine.9846-17 ratory tests, it is reported as a component of the complete blood cell count. It is calculated as the percentage of the standard deviation of the red blood cell size divided by the mean corpuscular volume. RDW elevation has been traditionally used as a surrogate for ineffective erythropoiesis (9) , in the investigation of the etiology of anemia (10) . Recently, many studies have reported an association between the RDW and adverse cardiovascular outcomes. The RDW is a novel prognostic marker in patients with HF (11) (12) (13) (14) , stroke (15) , myocardial infarction (16) , and pulmonary hypertension (17) .
The RDW and BNP are independent prognostic predictors in HF patients. However, the impact of the combined assessment of the RDW and BNP levels as a prognostic marker in HF is unknown. This study aimed to assess the prognostic value of the combination of the RDW and BNP in predicting the cardiovascular outcomes of HF patients.
Materials and Methods

Study population
This study was a single-center, retrospective cohort study. We enrolled 123 patients who were admitted to the Kagoshima University Hospital with a clinical diagnosis of HF from April 2008 to February 2011. Demographic information, medical history, vital signs and drug utilization data were routinely collected on admission. There were no patients with end-stage renal disease requiring hemodialysis, severe liver function abnormality (total bilirubin >3.0 mg/ dL), recent transfusion (within the past 3 months), or a condition associated with an increased RDW (i.e., hemolytic anemia), evident neoplastic metastasis to bone marrow, pregnancy, severe arthritis, or inflammatory bowel disease.
The study conformed to the Declaration of Helsinki and was approved by the institutional ethics committee of Kagoshima University Hospital.
Laboratory measurements and echocardiographic findings
Blood samples were collected from all patients on admission, and routine biochemical parameters were measured by standard techniques. Hematologic variables, such as the hemoglobin concentration, hematocrit, and RDW, were determined using a hematology analyzer (Sysmex XE-5000™ Automated Hematology System, Sysmex Corporation, Kobe, Japan). The reference range of normal RDW values was 12.0-16.0%. The BNP level was measured using a completely automated sample selective analyzer with a commercially available assay (Lumipulse G1200, Fujirebio, Tokyo, Japan).
On admission, the diameter of the left atrium (LAD), the diameter of the left ventricle (LVDd), and the left ventricular ejection fraction (LVEF) were evaluated by twodimensional echocardiography. The left ventricular inflow velocity pattern and estimated systolic pressure of the right ventricle were evaluated using pulse and continuous wave Doppler echocardiography, and the peak early diastolic velocity of the mitral annulus in the septum was evaluated using tissue Doppler echocardiography.
Follow-up and the clinical endpoints
The study endpoint was defined as cardiovascular death, and all study participants were followed up from the time that they were identified by our department. The mortality data were obtained from hospital medical records and/or by contacting the patient or relatives.
Statistical analysis
Continuous variables, including age, body mass index, RDW, and BNP, were expressed as the mean±SD. Categorical variables, including sex, etiology of HF, and history of underlying disease, were shown as the number of subjects and proportions (percentages). The optimal cut-off RDW and BNP values were considered to be those that yielded the highest sensitivity and specificity for predicting cardiovascular mortality in a receiver operating characteristics (ROC) curve analysis. Cumulative hazard curves were constructed to assess the association between the rates of cardiovascular death and the RDW or/and BNP level. Differences in the survival rate were evaluated using a log-rank test. The effects of variables on cardiovascular death were calculated by a Cox univariate proportional hazard regression analysis. The hazard ratio (HR) with 95% confidence interval demonstrated the risk of cardiovascular mortality. All statistical analyses were performed using the JMP Pro software program (version 11 for Windows, SAS Institute Inc, Cary, USA). p values of < 0.05 were considered to indicate statistical significance.
Results
The baseline characteristics and clinical outcomes
One hundred sixteen patients (94.3%) were followed up and twenty-four deaths occurred during the median observational period of 1,046 days, of which 22 were cardiovascular deaths (HF, n=15; sudden death, n=5; rupture of aortic aneurysm, n=1; stroke, n=1).
The clinical characteristics of the HF patients on admission are summarized in Table 1 . The mean age was 63.7± 14.3 years, and 80 patients (69.0%) were men. Sixty patients (51.7%) had an New York Heart Association (NYHA) functional class III or IV. The mean systolic blood pressure, LVDd, and LVEF were 109±20 mmHg, 62±9 mm and 32± 12%, respectively. The mean hemoglobin concentration, corpuscular volume, and corpuscular hemoglobin concentration were 13.3±2.2 g/dL, 91.8±5.5 μm 3 , and 33.2±2.9 g/dL, respectively; all values were within the normal range. The mean RDW and BNP were 14.5±2.0% and 626±593 pg/mL, respectively. The etiology of HF was dilated cardiomyopathy in 50.0% of the patients and ischemic cardiomyopathy in 
The association between cardiovascular death and RDW, BNP, and other variables
The results of a Cox proportional hazard analysis to investigate the factors that predict cardiovascular death are shown in Table 2 . The univariate analyses revealed that age, history of prior chronic heart failure (CHF), NYHA class, RDW, BNP, and ratio of the early transmitral flow velocity to the early mitral annular velocity (E/Eka´) were significant prognostic indices for survival, but that LVDd and LVEF were not. Furthermore, an age-adjusted bivariate analysis revealed that both the RDW and BNP on admission were significant predictors of cardiovascular mortality (RDW: HR 1.303, p = 0.0185; BNP: HR 1.001, p = 0.0051). In addition, the RDW remained a significant predictor after adjustment for BNP (HR 1.243, 95% CI 1.006-1.496, p = 0.0441). An ROC curve analysis was performed to assess the power of RDW and BNP for predicting cardiovascular death (Fig. 1) . At RDW = 14.9%, the area under the curve (AUC) was 0.59, and the sensitivity and specificity were 50.0% and 73.1%, respectively. In addition, when BNP was 686 pg/mL, the AUC was 0.58 and the sensitivity and specificity were 45.5% and 75.3%, respectively (Table 3) .
Survival curves of RDW and BNP in predicting cardiovascular death
The Kaplan-Meier survival curve was assessed using a cut-off RDW of 14.9% and a cut-off BNP value of 686 pg/ mL. Fig. 2A shows the Kaplan-Meier survival curves for patients with an RDW of !14.9% and those with an RDW of < 14.9%. The survival rate of patients with a high RDW was significantly greater than that of patients with a low RDW (p = 0.0037). In addition, patients with BNP values of !686 pg/mL had significantly higher rates of cardiovascular mortality than those with BNP values of < 686 pg/mL (Fig. 2B, p = 0.0101) . Furthermore, patients with both a high RDW and a high BNP levels (RDW !14.9% and BNP !686 pg/mL) showed the highest rate of mortality among the groups (Fig. 2C, p = 0.0003) .
Discussion
In the present study, we demonstrated that the RDW and BNP level on admission can individually predict cardiovascular mortality in HF patients. Moreover, the combined assessment of the RDW and BNP was more useful for predicting cardiovascular mortality in comparison to the RDW or BNP alone.
The clinical usefulness of the RDW is noteworthy because the RDW is routinely available with every complete blood count test and is relatively inexpensive to perform and minimally invasive. Several reports have demonstrated the value of the RDW for predicting adverse outcomes in HF patients (14, 18, 19) . The RDW is a useful prognostic marker not only for HF but also for atherosclerotic diseases, such as coronary artery disease (20) (21) (22) or carotid artery disease (23) . Various mechanisms have been suggested to underlie the association between the RDW and poor outcomes in patients with HF. Several studies have suggested that the RDW is related to the degree of inflammation, the inadequate production of erythropoietin, the renal function, or the nutritional status (24) (25) (26) . In this study, there were no significant differences in the serum albumin Days from enrollment 500 3,000 2,500 2,000 1,500 1,000 0 26.8±13.6 mg/dL, p = 0.1876), or creatinine (1.0±0.4 vs. 1.2 ±0.6 mg/dL, p = 0.0938) values of the low RDW (< 14.9%) and high RDW (> 14.9%) groups; however, both the renal function and the nutritional status tended to be worse in the high RDW group. We think that this is because the number of participants was too small to detect significant differences in these factors. Natriuretic peptides are principally produced within the heart and released into the circulation in response to elevated intra-cardiac filling pressure and myocardial wall stress (27) . Traditionally, BNP has been an important prognostic predictor in HF patients (7, 28, 29) . In the present study, patients with high RDW or BNP levels showed a significantly poorer prognosis than patients with low RDW or BNP levels. Moreover, the combination of RDW and BNP provided further prognostic value in HF patients. The combination of RDW and BNP appears to be a more powerful prognostic indicator for the clinical outcome of HF than either RDW or BNP alone, and the risk stratification of patients according to combination of RDW and BNP levels may be useful in the clinical setting.
Previous studies have demonstrated that both RDW and BNP were independent prognostic factors in HF patients. An increased RDW level in HF patients is associated with inflammation, which is a principal pathophysiologic finding in with endothelial dysfunction or HF (30, 31) . BNP is influenced by renal dysfunction (32, 33) . Although BNP is a widely accepted measure of severe HF, most geriatric patients who with HF have concomitant chronic kidney disease, and the severity of HF may be overestimated by BNP in these patients. Both RDW and BNP represent a different aspect of HF severity. Thus, the combined assessment of RDW and BNP for the prediction of mortality in HF patients may be worthy of consideration.
The present study is associated with several limitations. First, it was a single-center study with a relatively small number of patients. Because of the small sample size, the relationship between well-known predictors may either be insignificant or only marginally significant. In addition, we could not perform a multivariate analysis that included more than three items as explanatory variables because of the small study population. Consequently, we could not show the independence of RDW in the present study. Thus, a large prospective study is necessary to validate the results of the present study. Second, we examined the predictive power of variables at a single time point and did not explore the possibility that the variables may change over time, which might have affected the outcome. Finally, we lacked data regarding the erythropoietin, folate, vitamin B12, iron, and inflammatory cytokine levels, which might have contributed to the mechanism underlying the association between the RDW and the outcome.
In conclusion, the combined assessment of RDW and BNP concentrations may be useful for predicting mortality in patients with HF.
The authors state that they have no Conflict of Interest (COI).
